CHD2_HUMAN - dbPTM
CHD2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CHD2_HUMAN
UniProt AC O14647
Protein Name Chromodomain-helicase-DNA-binding protein 2
Gene Name CHD2
Organism Homo sapiens (Human).
Sequence Length 1828
Subcellular Localization Nucleus. Binds to myogenic gene promoters..
Protein Description DNA-binding helicase that specifically binds to the promoter of target genes, leading to chromatin remodeling, possibly by promoting deposition of histone H3.3. Involved in myogenesis via interaction with MYOD1: binds to myogenic gene regulatory sequences and mediates incorporation of histone H3.3 prior to the onset of myogenic gene expression, promoting their expression (By similarity)..
Protein Sequence MMRNKDKSQEEDSSLHSNASSHSASEEASGSDSGSQSESEQGSDPGSGHGSESNSSSESSESQSESESESAGSKSQPVLPEAKEKPASKKERIADVKKMWEEYPDVYGVRRSNRSRQEPSRFNIKEEASSGSESGSPKRRGQRQLKKQEKWKQEPSEDEQEQGTSAESEPEQKKVKARRPVPRRTVPKPRVKKQPKTQRGKRKKQDSSDEDDDDDEAPKRQTRRRAAKNVSYKEDDDFETDSDDLIEMTGEGVDEQQDNSETIEKVLDSRLGKKGATGASTTVYAIEANGDPSGDFDTEKDEGEIQYLIKWKGWSYIHSTWESEESLQQQKVKGLKKLENFKKKEDEIKQWLGKVSPEDVEYFNCQQELASELNKQYQIVERVIAVKTSKSTLGQTDFPAHSRKPAPSNEPEYLCKWMGLPYSECSWEDEALIGKKFQNCIDSFHSRNNSKTIPTRECKALKQRPRFVALKKQPAYLGGENLELRDYQLEGLNWLAHSWCKNNSVILADEMGLGKTIQTISFLSYLFHQHQLYGPFLIVVPLSTLTSWQREFEIWAPEINVVVYIGDLMSRNTIREYEWIHSQTKRLKFNALITTYEILLKDKTVLGSINWAFLGVDEAHRLKNDDSLLYKTLIDFKSNHRLLITGTPLQNSLKELWSLLHFIMPEKFEFWEDFEEDHGKGRENGYQSLHKVLEPFLLRRVKKDVEKSLPAKVEQILRVEMSALQKQYYKWILTRNYKALAKGTRGSTSGFLNIVMELKKCCNHCYLIKPPEENERENGQEILLSLIRSSGKLILLDKLLTRLRERGNRVLIFSQMVRMLDILAEYLTIKHYPFQRLDGSIKGEIRKQALDHFNADGSEDFCFLLSTRAGGLGINLASADTVVIFDSDWNPQNDLQAQARAHRIGQKKQVNIYRLVTKGTVEEEIIERAKKKMVLDHLVIQRMDTTGRTILENNSGRSNSNPFNKEELTAILKFGAEDLFKELEGEESEPQEMDIDEILRLAETRENEVSTSATDELLSQFKVANFATMEDEEELEERPHKDWDEIIPEEQRKKVEEEERQKELEEIYMLPRIRSSTKKAQTNDSDSDTESKRQAQRSSASESETEDSDDDKKPKRRGRPRSVRKDLVEGFTDAEIRRFIKAYKKFGLPLERLECIARDAELVDKSVADLKRLGELIHNSCVSAMQEYEEQLKENASEGKGPGKRRGPTIKISGVQVNVKSIIQHEEEFEMLHKSIPVDPEEKKKYCLTCRVKAAHFDVEWGVEDDSRLLLGIYEHGYGNWELIKTDPELKLTDKILPVETDKKPQGKQLQTRADYLLKLLRKGLEKKGAVTGGEEAKLKKRKPRVKKENKVPRLKEEHGIELSSPRHSDNPSEEGEVKDDGLEKSPMKKKQKKKENKENKEKQMSSRKDKEGDKERKKSKDKKEKPKSGDAKSSSKSKRSQGPVHITAGSEPVPIGEDEDDDLDQETFSICKERMRPVKKALKQLDKPDKGLNVQEQLEHTRNCLLKIGDRIAECLKAYSDQEHIKLWRRNLWIFVSKFTEFDARKLHKLYKMAHKKRSQEEEEQKKKDDVTGGKKPFRPEASGSSRDSLISQSHTSHNLHPQKPHLPASHGPQMHGHPRDNYNHPNKRHFSNADRGDWQRERKFNYGGGNNNPPWGSDRHHQYEQHWYKDHHYGDRRHMDAHRSGSYRPNNMSRKRPYDQYSSDRDHRGHRDYYDRHHHDSKRRRSDEFRPQNYHQQDFRRMSDHRPAMGYHGQGPSDHYRSFHTDKLGEYKQPLPPLHPAVSDPRSPPSQKSPHDSKSPLDHRSPLERSLEQKNNPDYNWNVRKT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
75PhosphorylationSESAGSKSQPVLPEA
HHCCCCCCCCCCHHH
41.2228188228
83AcetylationQPVLPEAKEKPASKK
CCCCHHHHCCCCCHH
65.6918528967
85AcetylationVLPEAKEKPASKKER
CCHHHHCCCCCHHHH
45.227430811
90AcetylationKEKPASKKERIADVK
HCCCCCHHHHHHHHH
50.137430821
103PhosphorylationVKKMWEEYPDVYGVR
HHHHHHHCCCHHCCC
8.0125262027
107PhosphorylationWEEYPDVYGVRRSNR
HHHCCCHHCCCCCCC
19.7925262027
125SumoylationEPSRFNIKEEASSGS
CCCCCCCCHHHCCCC
51.08-
125SumoylationEPSRFNIKEEASSGS
CCCCCCCCHHHCCCC
51.0817000644
125 (in isoform 3)Sumoylation-51.08-
129PhosphorylationFNIKEEASSGSESGS
CCCCHHHCCCCCCCC
38.2129255136
130PhosphorylationNIKEEASSGSESGSP
CCCHHHCCCCCCCCC
54.0829255136
132PhosphorylationKEEASSGSESGSPKR
CHHHCCCCCCCCCCH
30.4529255136
134PhosphorylationEASSGSESGSPKRRG
HHCCCCCCCCCCHHH
46.3923663014
136PhosphorylationSSGSESGSPKRRGQR
CCCCCCCCCCHHHHH
36.2130631047
156PhosphorylationEKWKQEPSEDEQEQG
HHHHCCCCHHHHHHC
57.8529507054
164PhosphorylationEDEQEQGTSAESEPE
HHHHHHCCCCCCCHH
25.1828450419
164 (in isoform 3)Phosphorylation-25.18-
165PhosphorylationDEQEQGTSAESEPEQ
HHHHHCCCCCCCHHH
36.5428450419
168PhosphorylationEQGTSAESEPEQKKV
HHCCCCCCCHHHHHH
59.1628450419
207PhosphorylationGKRKKQDSSDEDDDD
CCCCCCCCCCCCCCC
36.8823927012
207 (in isoform 3)Phosphorylation-36.88-
208PhosphorylationKRKKQDSSDEDDDDD
CCCCCCCCCCCCCCC
53.9923927012
208 (in isoform 3)Phosphorylation-53.99-
231PhosphorylationRRAAKNVSYKEDDDF
HHHHHCCCCCCCCCC
39.6222210691
232PhosphorylationRAAKNVSYKEDDDFE
HHHHCCCCCCCCCCC
17.7024144214
240PhosphorylationKEDDDFETDSDDLIE
CCCCCCCCCHHHHHH
40.5722617229
240 (in isoform 3)Phosphorylation-40.57-
242PhosphorylationDDDFETDSDDLIEMT
CCCCCCCHHHHHHHH
40.2122617229
242 (in isoform 3)Phosphorylation-40.21-
249PhosphorylationSDDLIEMTGEGVDEQ
HHHHHHHHCCCCCCC
21.2025849741
262PhosphorylationEQQDNSETIEKVLDS
CCCCCHHHHHHHHHH
33.97-
269PhosphorylationTIEKVLDSRLGKKGA
HHHHHHHHCCCCCCC
25.83-
277PhosphorylationRLGKKGATGASTTVY
CCCCCCCCCCCEEEE
41.7823401153
280PhosphorylationKKGATGASTTVYAIE
CCCCCCCCEEEEEEE
26.4223401153
281PhosphorylationKGATGASTTVYAIEA
CCCCCCCEEEEEEEE
21.5330206219
282PhosphorylationGATGASTTVYAIEAN
CCCCCCEEEEEEEEC
14.7130206219
284PhosphorylationTGASTTVYAIEANGD
CCCCEEEEEEEECCC
10.3623401153
293PhosphorylationIEANGDPSGDFDTEK
EEECCCCCCCCCCCC
56.5923401153
298PhosphorylationDPSGDFDTEKDEGEI
CCCCCCCCCCCCCCE
44.9523401153
354UbiquitinationEIKQWLGKVSPEDVE
HHHHHHCCCCHHHHH
37.0529967540
377PhosphorylationASELNKQYQIVERVI
HHHHHHHHHHHHHEE
11.2128152594
388PhosphorylationERVIAVKTSKSTLGQ
HHEEECCCCCCCCCC
34.4923312004
389PhosphorylationRVIAVKTSKSTLGQT
HEEECCCCCCCCCCC
20.9223312004
391PhosphorylationIAVKTSKSTLGQTDF
EECCCCCCCCCCCCC
28.7325954137
392PhosphorylationAVKTSKSTLGQTDFP
ECCCCCCCCCCCCCC
38.3525954137
396PhosphorylationSKSTLGQTDFPAHSR
CCCCCCCCCCCCCCC
37.5025954137
402PhosphorylationQTDFPAHSRKPAPSN
CCCCCCCCCCCCCCC
44.0723312004
408PhosphorylationHSRKPAPSNEPEYLC
CCCCCCCCCCCHHHH
56.8025954137
422PhosphorylationCKWMGLPYSECSWED
HHHCCCCHHHCCCCC
23.3429759185
423PhosphorylationKWMGLPYSECSWEDE
HHCCCCHHHCCCCCH
30.1329759185
435UbiquitinationEDEALIGKKFQNCID
CCHHHHCHHHHHHHH
43.34-
436UbiquitinationDEALIGKKFQNCIDS
CHHHHCHHHHHHHHH
47.14-
443PhosphorylationKFQNCIDSFHSRNNS
HHHHHHHHHHHCCCC
12.6329496963
472UbiquitinationPRFVALKKQPAYLGG
CCEEEEECCCCCCCC
63.4629967540
487PhosphorylationENLELRDYQLEGLNW
CCCCCCCCCCCCCHH
14.4629083192
498PhosphorylationGLNWLAHSWCKNNSV
CCHHHHHHHHHCCCE
28.6729083192
596PhosphorylationFNALITTYEILLKDK
HHHHEEEHHHHHCCC
7.7222817900
623SumoylationVDEAHRLKNDDSLLY
CCHHHHCCCCCCHHH
59.28-
623SumoylationVDEAHRLKNDDSLLY
CCHHHHCCCCCCHHH
59.2817000644
623UbiquitinationVDEAHRLKNDDSLLY
CCHHHHCCCCCCHHH
59.28-
627PhosphorylationHRLKNDDSLLYKTLI
HHCCCCCCHHHHHHH
24.1228555341
631UbiquitinationNDDSLLYKTLIDFKS
CCCCHHHHHHHCHHC
36.5029967540
637UbiquitinationYKTLIDFKSNHRLLI
HHHHHCHHCCCCEEE
46.7529967540
702SumoylationPFLLRRVKKDVEKSL
HHHHHHHHHHHHHCC
41.25-
702SumoylationPFLLRRVKKDVEKSL
HHHHHHHHHHHHHCC
41.2517000644
708PhosphorylationVKKDVEKSLPAKVEQ
HHHHHHHCCCHHHHH
26.53-
722PhosphorylationQILRVEMSALQKQYY
HHHHHHHHHHHHHHH
16.6024670416
728PhosphorylationMSALQKQYYKWILTR
HHHHHHHHHHHHHHH
17.66-
729PhosphorylationSALQKQYYKWILTRN
HHHHHHHHHHHHHHC
9.4326657352
734PhosphorylationQYYKWILTRNYKALA
HHHHHHHHHCHHHHH
14.0326657352
737PhosphorylationKWILTRNYKALAKGT
HHHHHHCHHHHHCCC
8.3722817900
744PhosphorylationYKALAKGTRGSTSGF
HHHHHCCCCCCCCHH
31.0229083192
747PhosphorylationLAKGTRGSTSGFLNI
HHCCCCCCCCHHHHH
18.9917192257
748PhosphorylationAKGTRGSTSGFLNIV
HCCCCCCCCHHHHHH
35.3829083192
749PhosphorylationKGTRGSTSGFLNIVM
CCCCCCCCHHHHHHH
29.2829083192
766PhosphorylationKKCCNHCYLIKPPEE
HHHCCCCEEECCCHH
12.15-
816SulfoxidationRVLIFSQMVRMLDIL
CEEEHHHHHHHHHHH
1.6831801345
828PhosphorylationDILAEYLTIKHYPFQ
HHHHHHHHCCCCCHH
27.38-
840PhosphorylationPFQRLDGSIKGEIRK
CHHHCCCCCCHHHHH
22.31-
842SumoylationQRLDGSIKGEIRKQA
HHCCCCCCHHHHHHH
52.79-
842SumoylationQRLDGSIKGEIRKQA
HHCCCCCCHHHHHHH
52.7917000644
913PhosphorylationQKKQVNIYRLVTKGT
CCCCEEEEEEECCCC
7.8422210691
917PhosphorylationVNIYRLVTKGTVEEE
EEEEEEECCCCHHHH
28.4827732954
958PhosphorylationLENNSGRSNSNPFNK
HCCCCCCCCCCCCCH
48.4023312004
960PhosphorylationNNSGRSNSNPFNKEE
CCCCCCCCCCCCHHH
47.3123312004
969PhosphorylationPFNKEELTAILKFGA
CCCHHHHHHHHHHCH
18.2223312004
988PhosphorylationKELEGEESEPQEMDI
HHHCCCCCCCCCCCH
50.7227732954
1010PhosphorylationETRENEVSTSATDEL
HHHCCCCCCHHHHHH
15.5130576142
1011PhosphorylationTRENEVSTSATDELL
HHCCCCCCHHHHHHH
27.7930576142
1012PhosphorylationRENEVSTSATDELLS
HCCCCCCHHHHHHHH
22.9717192257
1014PhosphorylationNEVSTSATDELLSQF
CCCCCHHHHHHHHHH
29.7628348404
1019PhosphorylationSATDELLSQFKVANF
HHHHHHHHHHCCCCC
46.31-
1028PhosphorylationFKVANFATMEDEEEL
HCCCCCCCCCCHHHH
19.5623312004
1062UbiquitinationVEEEERQKELEEIYM
HHHHHHHHHHHHHHH
71.18-
1068PhosphorylationQKELEEIYMLPRIRS
HHHHHHHHHHHHHHH
8.9021945579
1075O-linked_GlycosylationYMLPRIRSSTKKAQT
HHHHHHHHCCCCCCC
39.7330620550
1076O-linked_GlycosylationMLPRIRSSTKKAQTN
HHHHHHHCCCCCCCC
34.1030620550
1082PhosphorylationSSTKKAQTNDSDSDT
HCCCCCCCCCCCCCH
45.9430576142
1085PhosphorylationKKAQTNDSDSDTESK
CCCCCCCCCCCHHHH
40.8728176443
1087PhosphorylationAQTNDSDSDTESKRQ
CCCCCCCCCHHHHHH
50.8425849741
1089PhosphorylationTNDSDSDTESKRQAQ
CCCCCCCHHHHHHHH
46.2228176443
1091PhosphorylationDSDSDTESKRQAQRS
CCCCCHHHHHHHHHH
34.9228176443
1101PhosphorylationQAQRSSASESETEDS
HHHHHCCCCCCCCCC
43.5330576142
1103PhosphorylationQRSSASESETEDSDD
HHHCCCCCCCCCCCC
47.5328348404
1105PhosphorylationSSASESETEDSDDDK
HCCCCCCCCCCCCCC
55.1428348404
1108PhosphorylationSESETEDSDDDKKPK
CCCCCCCCCCCCCCH
36.3930576142
1122PhosphorylationKRRGRPRSVRKDLVE
HHCCCCCCHHHHHHC
29.0229214152
1132PhosphorylationKDLVEGFTDAEIRRF
HHHHCCCCHHHHHHH
45.19-
1141UbiquitinationAEIRRFIKAYKKFGL
HHHHHHHHHHHHHCC
42.84-
1165UbiquitinationRDAELVDKSVADLKR
HCHHHHCCHHHHHHH
39.0729967540
1209PhosphorylationPGKRRGPTIKISGVQ
CCCCCCCEEEEEEEE
37.41-
1213PhosphorylationRGPTIKISGVQVNVK
CCCEEEEEEEEEEHH
28.1023401153
1285SumoylationYGNWELIKTDPELKL
CCCEEECCCCCCCCC
60.54-
1285SumoylationYGNWELIKTDPELKL
CCCEEECCCCCCCCC
60.5417000644
1295UbiquitinationPELKLTDKILPVETD
CCCCCCCCCCCCCCC
40.6929967540
1338AcetylationVTGGEEAKLKKRKPR
CCCCHHHHHHCCCCC
65.2119824139
1347SumoylationKKRKPRVKKENKVPR
HCCCCCCCCCCCCCC
56.50-
1347SumoylationKKRKPRVKKENKVPR
HCCCCCCCCCCCCCC
56.5017000644
1356SumoylationENKVPRLKEEHGIEL
CCCCCCHHHHHCCCC
63.44-
1356SumoylationENKVPRLKEEHGIEL
CCCCCCHHHHHCCCC
63.4417000644
1364PhosphorylationEEHGIELSSPRHSDN
HHHCCCCCCCCCCCC
26.0423401153
1365PhosphorylationEHGIELSSPRHSDNP
HHCCCCCCCCCCCCC
38.2829255136
1369PhosphorylationELSSPRHSDNPSEEG
CCCCCCCCCCCCCCC
40.1229255136
1373PhosphorylationPRHSDNPSEEGEVKD
CCCCCCCCCCCCCCC
55.3129255136
1379SumoylationPSEEGEVKDDGLEKS
CCCCCCCCCCCCCCC
45.88-
1379SumoylationPSEEGEVKDDGLEKS
CCCCCCCCCCCCCCC
45.8817000644
1386PhosphorylationKDDGLEKSPMKKKQK
CCCCCCCCCCHHHHH
22.3529255136
1429PhosphorylationDKKEKPKSGDAKSSS
CCCCCCCCCCCCCCC
50.89-
1434PhosphorylationPKSGDAKSSSKSKRS
CCCCCCCCCCCCCCC
41.38-
1441PhosphorylationSSSKSKRSQGPVHIT
CCCCCCCCCCCEEEE
43.1318691976
1448PhosphorylationSQGPVHITAGSEPVP
CCCCEEEEECCCCCC
15.30-
1546MethylationKFTEFDARKLHKLYK
CCCHHHHHHHHHHHH
43.86-
1560PhosphorylationKMAHKKRSQEEEEQK
HHHHHHCCHHHHHHH
51.3130242111
1573PhosphorylationQKKKDDVTGGKKPFR
HHHHHCCCCCCCCCC
47.4124732914
1584PhosphorylationKPFRPEASGSSRDSL
CCCCCCCCCCCHHHH
37.2321406692
1586PhosphorylationFRPEASGSSRDSLIS
CCCCCCCCCHHHHHH
21.5021406692
1587PhosphorylationRPEASGSSRDSLISQ
CCCCCCCCHHHHHHC
43.5621406692
1590PhosphorylationASGSSRDSLISQSHT
CCCCCHHHHHHCCCC
26.8825159151
1593PhosphorylationSSRDSLISQSHTSHN
CCHHHHHHCCCCCCC
30.8129449344
1595PhosphorylationRDSLISQSHTSHNLH
HHHHHHCCCCCCCCC
23.1829449344
1597PhosphorylationSLISQSHTSHNLHPQ
HHHHCCCCCCCCCCC
36.6129449344
1598PhosphorylationLISQSHTSHNLHPQK
HHHCCCCCCCCCCCC
12.6429449344
1633PhosphorylationHPNKRHFSNADRGDW
CCCCCCCCCCCCCCC
25.6127251275
1637MethylationRHFSNADRGDWQRER
CCCCCCCCCCCHHHH
42.43-
1685MethylationRRHMDAHRSGSYRPN
CCCCCHHHCCCCCCC
44.42-
1686PhosphorylationRHMDAHRSGSYRPNN
CCCCHHHCCCCCCCC
23.4027251275
1688PhosphorylationMDAHRSGSYRPNNMS
CCHHHCCCCCCCCCC
21.1524719451
1695PhosphorylationSYRPNNMSRKRPYDQ
CCCCCCCCCCCCCCC
36.45-
1715PhosphorylationDHRGHRDYYDRHHHD
CCCCCCCCHHHCCCC
13.7625367160
1716PhosphorylationHRGHRDYYDRHHHDS
CCCCCCCHHHCCCCC
15.7025367160
1728PhosphorylationHDSKRRRSDEFRPQN
CCCCCCCCCCCCCCC
39.4130266825
1736PhosphorylationDEFRPQNYHQQDFRR
CCCCCCCCCHHHHHH
8.8520873877
1745PhosphorylationQQDFRRMSDHRPAMG
HHHHHHHCCCCCCCC
28.5829214152
1753PhosphorylationDHRPAMGYHGQGPSD
CCCCCCCCCCCCCCC
6.9528634298
1762PhosphorylationGQGPSDHYRSFHTDK
CCCCCCCCHHCCCCC
16.97-
1764PhosphorylationGPSDHYRSFHTDKLG
CCCCCCHHCCCCCCC
17.7623312004
1767PhosphorylationDHYRSFHTDKLGEYK
CCCHHCCCCCCCCCC
32.5823312004
1773PhosphorylationHTDKLGEYKQPLPPL
CCCCCCCCCCCCCCC
17.0823312004
1785PhosphorylationPPLHPAVSDPRSPPS
CCCCCCCCCCCCCCC
43.9630266825
1789PhosphorylationPAVSDPRSPPSQKSP
CCCCCCCCCCCCCCC
46.6930266825
1792PhosphorylationSDPRSPPSQKSPHDS
CCCCCCCCCCCCCCC
54.3323401153
1795PhosphorylationRSPPSQKSPHDSKSP
CCCCCCCCCCCCCCC
21.6023927012
1799PhosphorylationSQKSPHDSKSPLDHR
CCCCCCCCCCCCCCC
31.8123927012
1801PhosphorylationKSPHDSKSPLDHRSP
CCCCCCCCCCCCCCH
34.3523401153
1807PhosphorylationKSPLDHRSPLERSLE
CCCCCCCCHHHHHHH
30.3428355574
1821PhosphorylationEQKNNPDYNWNVRKT
HHHCCCCCCCCCCCC
24.2718691976
1828PhosphorylationYNWNVRKT-------
CCCCCCCC-------
33.0225159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CHD2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CHD2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CHD2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TRIM1_HUMANMID2physical
25416956
THAP1_HUMANTHAP1physical
25416956
TEKT1_HUMANTEKT1physical
25416956
TRI41_HUMANTRIM41physical
25416956
BEND7_HUMANBEND7physical
25416956
TRI41_HUMANTRIM41physical
21516116

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
615369Epileptic encephalopathy, childhood-onset (EEOC)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CHD2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-240 AND SER-242, ANDMASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-240; SER-242; SER-747;SER-1012; SER-1801 AND SER-1807, AND MASS SPECTROMETRY.

TOP